Atlas Trials

Study to Evaluate the Efficacy and Safety of Oral Administration With Nemonoxacin and Levofloxacin in Patients With CAP

Clinical trial NCT01529476 · COMPLETED

Trial details

NCT number
NCT01529476
Sponsor
TaiGen Biotechnology Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Pneumonia
Start date
2011-04-01
Primary completion
2012-08-01
Enrollment
540

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.